FR2317912A1 - Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central - Google Patents
Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux centralInfo
- Publication number
- FR2317912A1 FR2317912A1 FR7621862A FR7621862A FR2317912A1 FR 2317912 A1 FR2317912 A1 FR 2317912A1 FR 7621862 A FR7621862 A FR 7621862A FR 7621862 A FR7621862 A FR 7621862A FR 2317912 A1 FR2317912 A1 FR 2317912A1
- Authority
- FR
- France
- Prior art keywords
- acting
- pharmaceutical composition
- nervous system
- central nervous
- parenteral administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/596,488 US4016273A (en) | 1975-07-16 | 1975-07-16 | Sustained release forms of certain oxazepines for parenteral administration |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2317912A1 true FR2317912A1 (fr) | 1977-02-11 |
FR2317912B1 FR2317912B1 (fr) | 1979-04-13 |
Family
ID=24387483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7621862A Granted FR2317912A1 (fr) | 1975-07-16 | 1976-07-16 | Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central |
Country Status (11)
Country | Link |
---|---|
US (1) | US4016273A (fr) |
BE (1) | BE844203A (fr) |
CA (1) | CA1062159A (fr) |
DE (1) | DE2630394A1 (fr) |
DK (1) | DK319776A (fr) |
FI (1) | FI762053A (fr) |
FR (1) | FR2317912A1 (fr) |
GB (1) | GB1525425A (fr) |
NL (1) | NL7607918A (fr) |
PT (1) | PT65358B (fr) |
SE (1) | SE7608114L (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002013870A2 (fr) * | 2000-08-17 | 2002-02-21 | Mitokor, Inc. | Nouvelles formulations destinees a l'administration de molecules therapeutiques lipophiles |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6617321B2 (en) | 1997-09-30 | 2003-09-09 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine formulation |
US6199634B1 (en) | 1998-08-27 | 2001-03-13 | Viatchelav Ivanovich Selyakov | Method and apparatus for controlling the permeability of mineral bearing earth formations |
ATE309822T1 (de) * | 2000-04-19 | 2005-12-15 | Genentech Inc | Formulierungen mit verzögerter freisetzung enthaltend wachstumshormon |
DE10059020A1 (de) * | 2000-11-28 | 2002-05-29 | Gruenenthal Gmbh | Parenteral applizierbare Darreichungsformen |
ES2554106T3 (es) * | 2001-06-21 | 2015-12-16 | Genentech, Inc. | Formulación de liberación sostenida |
US6685971B2 (en) * | 2001-06-28 | 2004-02-03 | Rongxiang Xu | Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
CN1827766B (zh) * | 2001-06-28 | 2010-08-25 | 徐荣祥 | 体外细胞的培养方法 |
US6972195B2 (en) * | 2002-09-27 | 2005-12-06 | Rongxiang Xu | Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro |
BRPI0418304A (pt) * | 2004-01-07 | 2007-05-02 | Trimeris Inc | peptìdeo sintético, uso do mesmo, composição farmacêutica, seqüência de nucleotìdeos, e, métodos para inibição da transmissão de hiv para uma célula, para inibição da fusão de hiv, e para tratamento de um indivìduo infectado com hiv |
JP4940152B2 (ja) * | 2005-01-05 | 2012-05-30 | イーライ リリー アンド カンパニー | パモ酸オランザピン二水和物 |
ATE537183T1 (de) | 2006-02-02 | 2011-12-15 | Trimeris Inc | Hiv-fusionshemmerpeptide mit verbesserten biologischen eigenschaften |
DE502007003700D1 (de) * | 2006-07-27 | 2010-06-24 | Cognis Ip Man Gmbh | Verfahren zur Herstellung von Glycerin |
CN101678125A (zh) * | 2007-04-03 | 2010-03-24 | 特里梅里斯公司 | 用于递送抗病毒肽治疗剂的新制剂 |
WO2009042194A2 (fr) * | 2007-09-25 | 2009-04-02 | Trimeris, Inc. | Nouveaux procédés de synthèse pour des peptides antiviraux thérapeutiques |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3116203A (en) * | 1962-03-14 | 1963-12-31 | Hoffmann La Roche | Oleaginous systems |
US3546226A (en) * | 1963-03-01 | 1970-12-08 | A Wander Sa Dr | 11-basic-substituted dibenzoxazepines |
US3663696A (en) * | 1966-05-20 | 1972-05-16 | American Cyanamid Co | Treatment of depression with 2-chloro-11 - (piperazinyl)dibenz - (b,f)(1,4)oxazepines and acid addition salts thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3164520A (en) * | 1962-10-29 | 1965-01-05 | Olin Mathieson | Injectable steroid compositions containing at least 75% benzyl benzoate |
US3538216A (en) * | 1964-02-20 | 1970-11-03 | Lab De Rech Physiques S A R L | Injectable compositions of a drug suspended in an emulsion |
US3546220A (en) * | 1966-08-01 | 1970-12-08 | Abbott Lab | 2,3-dihydro-1h-pyrido-(2,3-b)(1,4)thiazines |
US3549621A (en) * | 1968-04-29 | 1970-12-22 | Harry Louis Yale | 12-substituted-6h-dibenz(b,f)(1,4)oxazocin-11(12h) ones |
US3891647A (en) * | 1970-08-06 | 1975-06-24 | Wander Ag Dr A | 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine |
US3773768A (en) * | 1970-10-26 | 1973-11-20 | American Cyanamid Co | 7-amino-2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine and salts thereof |
-
1975
- 1975-07-16 US US05/596,488 patent/US4016273A/en not_active Expired - Lifetime
-
1976
- 1976-06-28 GB GB26914/76A patent/GB1525425A/en not_active Expired
- 1976-06-28 CA CA255,781A patent/CA1062159A/fr not_active Expired
- 1976-07-06 DE DE19762630394 patent/DE2630394A1/de not_active Withdrawn
- 1976-07-12 PT PT65358A patent/PT65358B/pt unknown
- 1976-07-15 DK DK319776A patent/DK319776A/da not_active Application Discontinuation
- 1976-07-15 SE SE7608114A patent/SE7608114L/xx not_active Application Discontinuation
- 1976-07-15 FI FI762053A patent/FI762053A/fi not_active Application Discontinuation
- 1976-07-16 FR FR7621862A patent/FR2317912A1/fr active Granted
- 1976-07-16 NL NL7607918A patent/NL7607918A/xx not_active Application Discontinuation
- 1976-07-16 BE BE168963A patent/BE844203A/fr unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3116203A (en) * | 1962-03-14 | 1963-12-31 | Hoffmann La Roche | Oleaginous systems |
US3546226A (en) * | 1963-03-01 | 1970-12-08 | A Wander Sa Dr | 11-basic-substituted dibenzoxazepines |
US3663696A (en) * | 1966-05-20 | 1972-05-16 | American Cyanamid Co | Treatment of depression with 2-chloro-11 - (piperazinyl)dibenz - (b,f)(1,4)oxazepines and acid addition salts thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002013870A2 (fr) * | 2000-08-17 | 2002-02-21 | Mitokor, Inc. | Nouvelles formulations destinees a l'administration de molecules therapeutiques lipophiles |
WO2002013870A3 (fr) * | 2000-08-17 | 2003-02-06 | Apollo Biopharmaceutics Inc | Nouvelles formulations destinees a l'administration de molecules therapeutiques lipophiles |
Also Published As
Publication number | Publication date |
---|---|
DK319776A (da) | 1977-01-17 |
NL7607918A (nl) | 1977-01-18 |
BE844203A (fr) | 1977-01-17 |
GB1525425A (en) | 1978-09-20 |
PT65358A (en) | 1976-08-01 |
US4016273A (en) | 1977-04-05 |
FR2317912B1 (fr) | 1979-04-13 |
PT65358B (en) | 1978-01-09 |
SE7608114L (sv) | 1977-01-17 |
FI762053A (fr) | 1977-01-17 |
DE2630394A1 (de) | 1977-02-03 |
CA1062159A (fr) | 1979-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE849632A (fr) | Composition pharmaceutique pour l'administration orale | |
RO68479A (fr) | Procede pour la preparation des 1,4-dihydropyridinecarboxylates d'aralkyle | |
BE847283A (fr) | Nouveaux medicaments derives de l'indole, | |
FR2317912A1 (fr) | Nouvelle composition pharmaceutique pour l'administration parenterale, agissant sur le systeme nerveux central | |
FR2321655A1 (fr) | Moderateur de debit, notamment pour dispositifs d'injection intraveineuse | |
RO69608A (fr) | Procede pour la preparation des 1,2-benzisothiazole-3-ones | |
FR2333521A1 (fr) | Dispositif d'administration d'un liquide par voie parenterale | |
BE838823A (fr) | Procede pour la preparation de 1,2,5-dihydroxycholecalciferol | |
SU576021A3 (ru) | Установка дл непрерывной разливки металлов | |
FR2335522A1 (fr) | Procede de preparation d'androstene-4 diones-3,17 | |
FR2301976A1 (fr) | Systeme de reglage pour le retablissement de l'ortho | |
PH13669A (en) | 6-nor-6-isopropyl-9,10-dihydro-2'beta-methyl-5'alpha-benzyl-ergopetine | |
CH551200A (fr) | Composition pour l'enrobage des medicaments. | |
RO76667A (fr) | Procede pour la preparation des 2,4-dialkyamino-6-chlore-5-triazines | |
BE845327A (fr) | Procede de preparation de 4,4'-dihydroxy-3-3'-5-5'-tretralcoyldiphenylalcanes | |
PT64691B (fr) | Procede pour la preparation d'acides 6,11-di-hydro-11-oxo-dibenz /b,e/ oxepin-alcanoiques | |
RO70232A (fr) | Procede pour la preparation des 4-pyrazolile-4h-1,2,4-triazolile | |
BE845017A (fr) | Procede pour l'obtention d'alpha,alpha,alpha,alpha',alpha',-pentachloro-o-xylene | |
DK138895B (da) | Fremgangsmåde til fremstilling af 8-beta-(2'-pyrimidino-aminometyl)-ergolinderivater. | |
FR2318166A1 (fr) | Procede de preparation continue de 2,5-dioxo-1-oxa-2-phospholanes | |
CA1035359A (fr) | Derives de tetrahydro-1,2,3,4 isoquinoline substitues en 1 et disubstitues en 6,7 | |
BE810385A (fr) | Compositions medicamenteuses pour l'administration par voie orale | |
FR2323686A1 (fr) | Procede pour la preparation de la 2,2'-anhydro-1b-d-arabinofuranosyl-5-fluorocytosine | |
SE7709869L (sv) | N,n'n"-tricyklohexyl-n,n'n"-trimetyl-fosforsyratriamid | |
FR2314172A1 (fr) | Procede pour la preparation d'aminoanthraquinones a partir de nitroanthraquinones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |